A clearer understanding of the molecular mechanisms underlying the pathophysiological significance of HIF-1α-mediated K2P5.1 regulation in IBD patients is needed, and this can be done by using genome-wide and epigenome-wide association studies on DNA methylation and microRNA. Here, HIF1A is linked to inflammatory bowel disease.